Showing 1,501 - 1,520 results of 2,482 for search '"hepatitis"', query time: 0.07s Refine Results
  1. 1501

    HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design by Amy L. Kessler, Roel F. A. Pieterman, Wouter A. S. Doff, Karel Bezstarosti, Rachid Bouzid, Kim Klarenaar, Diahann T. S. L. Jansen, Robbie J. Luijten, Jeroen A. A. Demmers, Sonja I. Buschow

    Published 2025-01-01
    “…Here, we generated a unique, high-quality immunopeptidome dataset of human DCs pulsed with 12 hepatitis B virus (HBV)-based SLPs combined with either a TLR1/2 (Amplivant®) or TLR3 (PolyI:C) ligand. …”
    Get full text
    Article
  2. 1502

    Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma by Mehmet Akce, Elaine Chang, Mohammad Haeri, Mike Perez, Christie J. Finch, Mark M. Udden, Martha P. Mims

    Published 2016-01-01
    “…We present a case of a 53-year-old HIV-negative man with untreated hepatitis C viral infection who presented with abdominal pain and lymphadenopathy. …”
    Get full text
    Article
  3. 1503

    THE EFFECT OF QUERCETIN ON MORPHOLOGICAL AND BIOCHEMICAL CHANGES IN RAT LIVER UNDER 270TH DAY CENTRAL DEPRIVATION OF LUTEINIZING HORMONE SYNTHESIS by M.V. Rud, V.I. Shepitko, Ye.V. Stetsuk, O.Ye. Akimov

    Published 2022-04-01
    “…The development of the inflammatory process in the liver, including under the influence of hepatitis B and C viruses, is controlled by cells of the immune system, namely, sinusoidal endothelial cells, Ito cells and Kupffer cells. …”
    Get full text
    Article
  4. 1504

    A machine learning based algorithm accurately stages liver disease by quantification of arteries by Zhengxin Li, Xin Sun, Zhimin Zhao, Qiang Yang, Yayun Ren, Xiao Teng, Dean C. S. Tai, Ian R. Wanless, Jörn M. Schattenberg, Chenghai Liu

    Published 2025-01-01
    “…We developed qVessel to quantify the arterial density (AD) in liver biopsies with chronic disease of varied etiology and stage. 46 needle liver biopsy samples with chronic hepatitis B (CHB), 48 with primary biliary cholangitis (PBC) and 43 with metabolic dysfunction-associated steatotic liver disease (MASLD) were collected at the Shuguang Hospital. …”
    Get full text
    Article
  5. 1505

    Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy by Dong-Mei Zhu, Jing Xie, Chun-Yan Ye, Mei-Yun Qian, Yuan Xue

    Published 2020-01-01
    “…This study aimed to evaluate the risk factors of HCC development in patients with hepatitis B virus (HBV)-related DC and who underwent long-term antiviral therapy. …”
    Get full text
    Article
  6. 1506

    A Reverse Design Method for Convective PCR Chips Featuring Precise Control of Steady-State Flow Fields by Chenfei Li, Yaping Xie, Haochen Yong, Xin Zhao, Xingxing Ke, Zhigang Wu

    Published 2025-01-01
    “…Ultimately, a reaction chamber was designed based on the actual amplification needs of 2019-nCoV and hepatitis B virus, and successful amplification was achieved using a self-developed temperature control platform.…”
    Get full text
    Article
  7. 1507

    <i>Ajuga reptans</i> L. Herb Extracts: Phytochemical Composition and Pharmacological Activity Screening by Svitlana Maliuvanchuk, Andriy Grytsyk, Oksana Popadynets, Taras Kotyk, Ain Raal, Oleh Koshovyi

    Published 2025-01-01
    “…<i>A. reptans</i> herb extracts are practically non-toxic, exhibit hepatoprotective activity (dose 25 mg/kg) in experimental carbon tetrachloride-induced hepatitis, moderate anti-inflammatory activity (dose 100 mg/kg) in carrageenan-induced edema models, and possess significant local hemostatic (reducing bleeding time by 40.6%) and wound-healing properties (complete wound healing after 9 days). …”
    Get full text
    Article
  8. 1508

    Generation of Mature Nα-Terminal Acetylated Thymosin α1 by Cleavage of Recombinant Prothymosin α by Bo Liu, Xin Gong, Shaohong Chang, Peng Sun, Jun Wu

    Published 2013-01-01
    “…Nα-terminal acetylated thymosin α1 (Tα1), a 28-amino-acid peptide, is an immune modifier that has been used in the clinic to treat hepatitis B and C virus (HBV/HCV) infections. We previously documented Nα-terminal acetylation of recombinant prothymosin α (ProTα) in E. coli. …”
    Get full text
    Article
  9. 1509

    Liver lobes and cirrhosis: Diagnostic insights from lobar ratios by Kriti Pandey, Debabrata Dash, Raj Kumar Koiri

    Published 2025-01-01
    “…Globally it accounts for 4 ​% of all deaths. Alcohol, viral hepatitis, and non-alcoholic fatty liver disease are the most common cause of cirrhosis. …”
    Get full text
    Article
  10. 1510

    Disseminated Histoplasmosis as an AIDS-Defining Illness Presenting as Fever of Unknown Origin in an 11-Year-Old Female by Kathryn E. Kalata, Christina Osborne, Amy Willis, Kacey Navarro, Laura Z. Fenton, Christiana Smith

    Published 2019-01-01
    “…Past medical history included severe bronchiolitis, varicella, and hepatitis A as a child. Upon admission, her physical exam was significant for nontender cervical lymphadenopathy, intermittent erythematous papules on the upper extremities, and mild abdominal tenderness. …”
    Get full text
    Article
  11. 1511

    TepiSense: A Social Computing-Based Real-Time Epidemic Surveillance System Using Artificial Intelligence by Bilal Tahir, Muhammad Amir Mehmood

    Published 2025-01-01
    “…To test the performance of our system, we build a dataset of Twitter Epidemic Surveillance Corpus (TESC) containing 23.9K English and 13K labelled Urdu tweets related to six diseases: COVID19, hepatitis, malaria, flu, dengue, and HIV/AIDS. Our results show that mBERT LLM achieves the highest F-measure values of 0.96 and 0.83 for topic and indication tweets classification, respectively. …”
    Get full text
    Article
  12. 1512

    Multisite Infection with Mycobacterium abscessus after Replacement of Breast Implants and Gluteal Lipofilling by Eva Rüegg, Alexandre Cheretakis, Ali Modarressi, Stephan Harbarth, Brigitte Pittet-Cuénod

    Published 2015-01-01
    “…Adequate antibiotic treatment was stopped after seven days for drug-related hepatitis. At entrance, gluteal puncture for bacterial analysis was performed. …”
    Get full text
    Article
  13. 1513

    Insights into the binding selectivity of harzianoic acids A and B to tetraspanin CD81 by Gérard Vergoten, Christian Bailly

    Published 2023-11-01
    “…They display anticancer and antiviral effects, reducing the entry of hepatitis C virus (HCV) into hepatocarcinoma cells. …”
    Get full text
    Article
  14. 1514

    Targeted delivery of curcumin and CM11 peptide against hepatocellular carcinoma cells based on binding affinity of PreS1-coated chitosan nanoparticles to SB3 protein by Danial Rahmani, Ramezan Ali Taheri, Mehrdad Moosazadeh Moghaddam

    Published 2025-01-01
    “…SB3 protein is the specific antigen of HCC and the PreS1 peptide is a part of the hepatitis B antigen, which can specifically bind to the SB3 protein. …”
    Get full text
    Article
  15. 1515

    Neglected tropical diseases in Yemen: a systematic review of epidemiology and public health challenges by Ibrahim Ahmed Ahmed Alhothily, Rahmat Dapari, Nazri Che Dom

    Published 2025-02-01
    “…Results Viral NTDs were the most frequently reported, accounting for 39% of the articles, followed by bacterial (26%), helminthic (21%), and protozoal NTDs (15%). Dengue virus, hepatitis B and C viruses were the most prominent viral pathogens, while bacterial NTDs were primarily caused by Escherichia coli, cholera, and Salmonella. …”
    Get full text
    Article
  16. 1516

    Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015 by A. I. Dolgushina, Ye. R. Olevskaya, A. N. Tarasov, M. S. Kazakova, A. Yu. Markina

    Published 2018-08-01
    “…However objectively restrictions in utilization of the available range of treatment-and-prophylactic actions for treatment of LC in the outcome of viral hepatitis (in drug addicts, alcoholic or asocial patients) due to their low treatment compliance.…”
    Get full text
    Article
  17. 1517
  18. 1518

    Vaccination and Malaria Prevention among International Travelers Departing from Athens International Airport to African Destinations by Androula Pavli, Athina Spilioti, Paraskevi Smeti, Stavros Patrinos, Helena C. Maltezou

    Published 2014-01-01
    “…Only 47% sought pretravel consultation. Hepatitis A, typhoid, and meningococcal vaccines were administered to 49.8%, 28%, and 26.6%, respectively, and malaria chemoprophylaxis to 66.8% of those who visited sub-Saharan Africa. …”
    Get full text
    Article
  19. 1519

    Evolution and importance of Molecular Microbiology in the Laboratory of the Provincial Center for Hygiene, Epidemiology and Microbiology by María de Lourdes Sánchez Alvarez, Rafael Abreu Duarte, Edenis García Alvarez, Adrian Fernández García, Ermis Alexander González Martínez, Maidelys Mendoza Acosta

    Published 2024-05-01
    “…The laboratory became relevant due to the arrival of the 2019 new coronavirus pandemic: 511,225 nasopharyngeal exudate samples and 14,568 determinations were processed for the diagnosis of human immunodeficiency viruses, hepatitis C and B, and human papilloma carried out on the COBAS 4800® platform. …”
    Get full text
    Article
  20. 1520

    Transmitted blood infections and emerging vector-borne diseases in blood donors in northern Portugal by Ana Mota, Margarida Fonseca Cardoso

    Published 2025-01-01
    “…The proportions of human immunodeficiency viruses, syphilis, human hepatitis viruses type B and C varied between 0 and 44/100,000 donations. …”
    Get full text
    Article